Jay I. Goodman

4.7k total citations
110 papers, 3.6k citations indexed

About

Jay I. Goodman is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jay I. Goodman has authored 110 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 46 papers in Cancer Research and 21 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jay I. Goodman's work include Carcinogens and Genotoxicity Assessment (39 papers), Epigenetics and DNA Methylation (33 papers) and DNA Repair Mechanisms (17 papers). Jay I. Goodman is often cited by papers focused on Carcinogens and Genotoxicity Assessment (39 papers), Epigenetics and DNA Methylation (33 papers) and DNA Repair Mechanisms (17 papers). Jay I. Goodman collaborates with scholars based in United States, United Kingdom and Netherlands. Jay I. Goodman's co-authors include Jennifer L. Counts, Robert L. Smith, Timothy B. Adams, Philip S. Portoghese, John Doull, Bernard M. Wagner, James E. Trosko, V.J. Feron, William J. Waddell and Lawrence J. Marnett and has published in prestigious journals such as Cell, Nucleic Acids Research and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jay I. Goodman

110 papers receiving 3.4k citations

Peers

Countries citing papers authored by Jay I. Goodman

Since Specialization

Citations

This map shows the geographic impact of Jay I. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay I. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay I. Goodman more than expected).

Fields of papers citing papers by Jay I. Goodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay I. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay I. Goodman. The network helps show where Jay I. Goodman may publish in the future.

Co-authorship network of co-authors of Jay I. Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Jay I. Goodman. A scholar is included among the top collaborators of Jay I. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay I. Goodman. Jay I. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incorporation of an epigenetic evaluation into safety assessment: What we first need to know 2017 ·Current Opinion in Toxicology ·Jay I. Goodman	2
2	What Do We Need to Know prior to Thinking about Incorporating an Epigenetic Evaluation into Safety Assessments?2 2010 ·Toxicological Sciences ·Jay I. Goodman, (unknown), (unknown), Darlene Dixon, Yvonne P. Dragan, (unknown), Reza J. Rasoulpour, Robert C. Sills, Richard D. Storer, Douglas C. Wolf, Syril Pettit	39
3	Multiple Genes Exhibit Phenobarbital-Induced Constitutive Active/Androstane Receptor–Mediated DNA Methylation Changes during Liver Tumorigenesis and in Liver Tumors 2009 ·Toxicological Sciences ·Jennifer M. Phillips, Jay I. Goodman	27
4	Phenobarbital Elicits Unique, Early Changes in the Expression of Hepatic Genes that Affect Critical Pathways in Tumor-Prone B6C3F1 Mice 2009 ·Toxicological Sciences ·Jennifer M. Phillips, Lyle D. Burgoon, Jay I. Goodman	26
5	A Review of Large Granular Lymphocytic Leukemia in Fischer 344 Rats as an Initial Step Toward Evaluating the Implication of the Endpoint to Human Cancer Risk Assessment 2007 ·Toxicological Sciences ·Johnson Thomas, Joseph K. Haseman, Jay I. Goodman, Jerrold M. Ward, Thomas P. Loughran, P.J. Spencer	26
6	Altered Methylation in Gene-Specific and GC-Rich Regions of DNA Is Progressive and Nonrandom during Promotion of Skin Tumorigenesis 2006 ·Toxicological Sciences ·Ammie N. Bachman, (unknown), David J. Doolittle, Jay I. Goodman	15
7	Orphan Nuclear Receptor Constitutive Active/Androstane Receptor–Mediated Alterations in DNA Methylation during Phenobarbital Promotion of Liver Tumorigenesis 2006 ·Toxicological Sciences ·Jennifer M. Phillips, Yukio Yamamoto, Masahiko Negishi, Robert R. Maronpot, Jay I. Goodman	38
8	Phenobarbital Induces Progressive Patterns of GC-Rich and Gene-Specific Altered DNA Methylation in the Liver of Tumor-Prone B6C3F1 Mice 2006 ·Toxicological Sciences ·Ammie N. Bachman, Jennifer M. Phillips, Jay I. Goodman	51
9	Criteria for the safety evaluation of flavoring substances 2005 ·Food and Chemical Toxicology ·Robert L. Smith, Samuel M. Cohen, John Doull, V.J. Feron, Jay I. Goodman, Lawrence J. Marnett, I.C. Munro, Philip S. Portoghese, William J. Waddell, Bernard M. Wagner, Timothy B. Adams	48
10	The FEMA GRAS assessment of hydroxy- and alkoxy-substituted benzyl derivatives used as flavor ingredients 2005 ·Food and Chemical Toxicology ·Timothy B. Adams, Samuel M. Cohen, John Doull, V.J. Feron, Jay I. Goodman, Lawrence J. Marnett, I.C. Munro, Philip S. Portoghese, Robert L. Smith, William J. Waddell, Bernard M. Wagner	43
11	Epigenetics and DNA Methylation Come of Age in Toxicology 2002 ·Toxicological Sciences ·(unknown), Jay I. Goodman	88
12	Repeated Inhalation Exposure to Octamethylcyclotetrasiloxane Produces Hepatomegaly, Transient Hepatic Hyperplasia, and Sustained Hypertrophy in Female Fischer 344 Rats in a Manner Similar to Phenobarbital 2001 ·Toxicology and Applied Pharmacology ·James M. McKim, (unknown), Paul A. Jean, (unknown), (unknown), Robert Schoonhoven, James A. Swenberg, Jay I. Goodman, R. H. Gallavan, Robert G. Meeks	38
13	Reevaluation of the Cancer Potency Factor of Toxaphene: Recommendations from a Peer Review Panel 2000 ·Toxicological Sciences ·Jay I. Goodman	14
14	The FEMA GRAS Assessment of trans-Anethole Used as a Flavouring Substance 1999 ·Food and Chemical Toxicology ·Paul M. Newberne, Robert L. Smith, John Doull, Jay I. Goodman, I.C. Munro, Philip S. Portoghese, Bernard M. Wagner, Carrol S. Weil, L.A. Woods, Timothy B. Adams, (unknown), R.A. Ford	101
15	The traditional toxicologic paradigm is correct: dose influences mechanism. 1998 ·Environmental Health Perspectives ·Jay I. Goodman	8
16	Alterations in the methylation status and expression of the raf oncogene in phenobarbital‐induced and spontaneous B6C3F1 mouse liver tumors 1994 ·Molecular Carcinogenesis ·(unknown), Margaret L. Harbison, R. Michael McClain, Jay I. Goodman	51
17	Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion 1994 ·Molecular Carcinogenesis ·Jennifer L. Counts, Jay I. Goodman	71
18	Infection of rat liver epithelial cells with v‐Ha‐ras: Correlation between oncogene expression, gap junctional communication, and tumorigenicity 1990 ·Molecular Carcinogenesis ·Adriaan W. de Feijter, (unknown), Christopher M. Weghorst, James E. Klaunig, Jay I. Goodman, Chia Cheng Chang, Randall J. Ruch, James E. Trosko	55
19	Quantitative studies on the in vitro metabolic activation of dimethylnitrosamine by rat liver postmitochondrial supernatant. 1984 ·Environmental Health Perspectives ·David J. Doolittle, Jay I. Goodman	2
20	Evidence for DNA repair synthesis and turnover in rat liver following ingestion of 3'-methyl-4-dimethylaminoazobenzene. 1972 ·PubMed ·Jay I. Goodman, Van R. Potter	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact